Studies conducted on post-COVID patients during follow-up found that the levels of interferon-alpha (IFN-α) and IFN-β were significantly lower in individuals who developed fibrotic lung changes compared to those without fibrosis. This evidence concerns the gene IFNB1 and fibrosis.